Literature DB >> 2898594

Rational programme for screening travellers for antibodies to hepatitis A virus.

J V Parry1, C P Farrington, K R Perry, P A Waight, P P Mortimer, E Miller.   

Abstract

A blood test and a saliva test for antibody to hepatitis A virus (anti HAV) were offered to British travellers seeking human normal immunoglobulin (HNIG) prophylaxis. The specimens were tested by an IgG capture and a competitive radioimmunoassay (GACRIA, COMPRIA). By GACRIA 211 subjects were anti-HAV positive and 358 anti-HAV negative on both serum and saliva. 10 other seropositive subjects had weakly positive saliva reactions. There were three discrepant results. For the population investigated HNIG use could be minimised at no extra cost by first testing the saliva of those greater than 40 years old, frequent or long-stay travellers, those born in HAV endemic areas, and those with a history of jaundice. Of the 51% of travellers tested for these reasons 20% were anti-HAV positive. They made up 76% of all those with antibody.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898594     DOI: 10.1016/s0140-6736(88)92250-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  An outbreak of hepatitis A in Gloucester, UK.

Authors:  F A Majeed; J M Stuart; K A Cartwright; R Room; J R Gilkes; M C Smith; B E Watson
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

2.  Prophylaxis against hepatitis A for travel.

Authors:  K R Neal; E M Dunbar
Journal:  BMJ       Date:  1990-04-28

3.  New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva.

Authors:  J J Ochnio; D W Scheifele; M Ho; L A Mitchell
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Prophylaxis against hepatitis A for travel.

Authors:  P Moore; P Oakeshott; J Logan; J Law; D M Harris
Journal:  BMJ       Date:  1990-03-17

5.  Investigation of an outbreak of hepatitis A simplified by salivary antibody testing.

Authors:  A R Bull; K J Kimmance; J V Parry; K R Perry
Journal:  Epidemiol Infect       Date:  1989-10       Impact factor: 2.451

6.  Current hepatitis A status in Canada.

Authors:  J Wu; S Zou; A Giulivi
Journal:  Can J Infect Dis       Date:  2001-11

Review 7.  Immunizations for foreign travel.

Authors:  D R Hill
Journal:  Yale J Biol Med       Date:  1992 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.